You just read:

Bausch + Lomb and Nicox Announce the Publication of Latanoprostene Bunod Ophthalmic Solution 0.024% Phase 3 Study Results in American Journal of Ophthalmology

News provided by

Valeant Pharmaceuticals International, Inc.

06 Jul, 2016, 01:30 ET